Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. H. Lundbeck A/S
  6. News
  7. Summary
    LUN   DK0010287234

H. LUNDBECK A/S

(LUN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

H Lundbeck A/S : Lundbeck Drug Improves Symptoms in People With Major Depressive Disorder, Anxiety Disorder

05/03/2021 | 02:36am EDT


ę MT Newswires 2021
All news about H. LUNDBECK A/S
09/20H LUNDBECK A/S : A family portrait of the brain
PU
09/14HERANTIS PHARMA OYJ : Names Chairman of New Scientific Advisory Board
MT
08/18H LUNDBECK A/S : Drugmaker Lundbeck lowers sales outlook as generic competition bites
RE
08/18H LUNDBECK A/S : Lundbeck continues to deliver solid growth for strategic brands and the f..
AQ
08/18H. Lundbeck A/S Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
08/04H LUNDBECK A/S : Lundbeck enters strategic research collaboration with Rgenta Therapeutics..
PU
08/04Rgenta Therapeutics, Inc. Enters into a Collaboration with H. Lundbeck A/S
CI
07/22H LUNDBECK A/S : What do you mean brain health?
PU
07/01Denovo Biopharma LLC Announces In-Licenses Late-Stage Alzheimer's Disease Asset from H...
CI
06/15#1VOICESUMMIT : Partnering with the advocacy community to further brain health and neurosc..
PU
More news
Analyst Recommendations on H. LUNDBECK A/S
More recommendations
Financials
Sales 2021 16 422 M 2 588 M 2 588 M
Net income 2021 1 453 M 229 M 229 M
Net Debt 2021 2 161 M 341 M 341 M
P/E ratio 2021 24,5x
Yield 2021 1,59%
Capitalization 35 488 M 5 602 M 5 592 M
EV / Sales 2021 2,29x
EV / Sales 2022 2,01x
Nbr of Employees 5 603
Free-Float 30,7%
Chart H. LUNDBECK A/S
Duration : Period :
H. Lundbeck A/S Technical Analysis Chart | LUN | DK0010287234 | MarketScreener
Technical analysis trends H. LUNDBECK A/S
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 178,60 DKK
Average target price 229,60 DKK
Spread / Average Target 28,6%
EPS Revisions
Managers and Directors
Deborah L. Dunsire President & Chief Executive Officer
Anders G÷tzsche Chief Financial Officer & Executive Vice President
Lars S°ren Rasmussen Chairman
Lars Bang Executive VP-Supply Operations & Engineering
Johan Luthman EVP & Head-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
H. LUNDBECK A/S-14.46%5 598
JOHNSON & JOHNSON4.75%433 991
ROCHE HOLDING AG10.87%324 441
PFIZER, INC.19.40%247 760
NOVO NORDISK A/S51.58%233 750
ELI LILLY AND COMPANY37.51%210 490